Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Interleukin-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 93 Carcinoma, Renal Cell 33 Neoplasm Metastasis 30 Leukemia, Myeloid, Acute 28 Breast Neoplasms 22 Neoplasms 20 Lymphoma, Non-Hodgkin 19 Leukemia 18 Kidney Neoplasms 17 Carcinoma, Non-Small-Cell Lung 16 Skin Neoplasms 15 Ovarian Neoplasms 15 Neuroblastoma 15 Recurrence 13 Lymphoma 13 Colorectal Neoplasms 13 Leukemia, Lymphocytic, Chronic, B-Cell 12 Myelodysplastic Syndromes 9 Uveal Melanoma 8 Uterine Cervical Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Follicular 8 Multiple Myeloma 7 Head and Neck Neoplasms 7 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Lymphoma, Large B-Cell, Diffuse 6 Lung Neoplasms 6 Hodgkin Disease 6

Interventions

Temozolomide 143 Bevacizumab 63 Radiotherapy 60 Magnetic Resonance Spectroscopy 58 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 22 Radiation 19 Carmustine 18 Aminolevulinic Acid 18 Specimen Handling 17 Nivolumab 16 Blood Specimen Collection 16 Lomustine 15 Biopsy 15 pembrolizumab 13 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 10 X-Rays 10 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 Surveys and Questionnaires 8 Magnetic Resonance Imaging 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡